Form 4: Executive VP Collier Granted HealthStream RSUs
Insider Transaction Report
HealthStream's Executive Vice President, Michael Manning Collier, was granted 3,639 Restricted Share Units, vesting over four years.
Summary
- Michael Manning Collier, Executive Vice President of HealthStream Inc. (HSTM), was granted 3,639 Restricted Share Units (RSUs).
- Each RSU represents the contingent right to receive one share of common stock upon vesting of the unit.
- The RSUs are subject to a four-year vesting schedule, contingent upon continued service at the time of vesting.
- Vesting occurs in tranches: 15% on March 18, 2027, 20% on March 18, 2028, 30% on March 18, 2029, and the remaining 35% on March 18, 2030.
- Collier also beneficially owns 54,782 shares of common stock directly.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies continued executive commitment and aligns management's interests with long-term shareholder value through performance-based compensation.
Positives
- The grant of 3,639 Restricted Share Units (RSUs) to Executive Vice President Michael Manning Collier aligns his long-term interests with those of shareholders.
- The multi-year vesting schedule incentivizes continued service and performance from a key executive.
Future Outlook
The four-year vesting schedule for the Restricted Share Units indicates a long-term incentive structure for the Executive Vice President, aligning future performance with shareholder value.
Industry Context
StockSavvy.ai notes that RSU grants are a common form of executive compensation in the healthcare technology sector, designed to retain key talent and align management incentives with long-term company performance.
Comparison to Industry Standards
- RSU grants with multi-year vesting schedules are standard practice for executive compensation across various industries, including healthcare technology.
- Companies like Cerner (now Oracle Health) and Epic Systems also utilize similar long-term incentive plans to retain executives and foster commitment to strategic goals.
- The specific grant size of 3,639 units would need to be benchmarked against peer companies of similar market capitalization and executive roles to assess its relative competitiveness.
Stakeholder Impact
- Shareholders: Potential positive impact due to increased alignment of executive incentives with long-term company performance.
- Employees: May signal stability in executive leadership and a commitment to long-term growth.
Next Steps
- Vesting of 15% of RSUs on March 18, 2027, contingent on continued service.
- Vesting of 20% of RSUs on March 18, 2028, contingent on continued service.
- Vesting of 30% of RSUs on March 18, 2029, contingent on continued service.
- Vesting of 35% of RSUs on March 18, 2030, contingent on continued service.
Key Dates
| Date | Description |
|---|---|
| 03/18/2026 | Date of earliest transaction (RSU grant date) |
| 03/24/2026 | Signature date of the reporting person |
| 03/18/2027 | First vesting tranche (15%) of Restricted Share Units |
| 03/18/2028 | Second vesting tranche (20%) of Restricted Share Units |
| 03/18/2029 | Third vesting tranche (30%) of Restricted Share Units |
| 03/18/2030 | Final vesting tranche (35%) of Restricted Share Units |
Recommendation
holdThis Form 4 reports a routine grant of Restricted Share Units to an executive, which is a standard component of compensation designed to align management incentives with long-term shareholder value. It does not present new information that would significantly alter the investment thesis for HealthStream, thus a 'hold' recommendation is appropriate.
Keywords
HealthStream, HSTM, Restricted Share Units, RSU, Executive Compensation, Insider Transaction, Form 4, Michael Collier
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.